Page last updated: 2024-09-03

ci 934 and ciprofloxacin

ci 934 has been researched along with ciprofloxacin in 20 studies

Compound Research Comparison

Studies
(ci 934)
Trials
(ci 934)
Recent Studies (post-2010)
(ci 934)
Studies
(ciprofloxacin)
Trials
(ciprofloxacin)
Recent Studies (post-2010) (ciprofloxacin)
330216,0601,3316,092

Protein Interaction Comparison

ProteinTaxonomyci 934 (IC50)ciprofloxacin (IC50)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.41
DNA gyrase subunit BBacillus subtilis subsp. subtilis str. 1686.3
DNA gyrase subunit ABacillus subtilis subsp. subtilis str. 1686.3
Cytochrome P450 3A4Homo sapiens (human)0.31
DNA gyrase subunit BStaphylococcus aureus4.32
DNA gyrase subunit AEscherichia coli K-120.6845
DNA gyrase subunit BEscherichia coli K-120.5632
DNA topoisomerase 4 subunit BStaphylococcus aureus6.485
DNA topoisomerase 4 subunit AStaphylococcus aureus4.8011
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.41
DNA gyrase subunit AStaphylococcus aureus4.32
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.41
DNA topoisomerase 4 subunit ABacillus subtilis subsp. subtilis str. 1681.7
DNA topoisomerase 4 subunit BBacillus subtilis subsp. subtilis str. 1681.7
GABA theta subunitRattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.41

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-199015 (75.00)18.7374
1990's4 (20.00)18.2507
2000's1 (5.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, MA; Domagala, JM; Mailloux, GB; Roland, GE; Suto, MJ1
Bridges, AJ; Culbertson, TP; Domagala, JM; Gambino, L; Hagen, SE; Karrick, G; Porter, K; Sanchez, JP; Sesnie, JA; Spense, FG1
Culbertson, TP; Gambino, L; Sanchez, JP; Sesnie, JA1
Domagala, JM; Heifetz, CL; Hutt, MP; Mich, TF; Nichols, JB; Solomon, M; Worth, DF1
Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB1
García-March, FJ; Jaén-Oltra, J; Pérez-Giménez, F; Salabert-Salvador, MT; Tomás-Vert, F1
Amyes, SG; Barnes, AC; Hastings, TS; Lewin, CS1
Avesani, V; Delmee, M1
Verbist, L1
Caputo, GM; Eliopoulos, GM; Moellering, RC; Reiszner, E1
Gottschall, S; Kim, MJ; Randall, EL; Weiser, M1
Berlin, OG; Bruckner, DA; Young, LS1
Habiyaremye, I; Vandepitte, J; Verbist, L1
Boothman, C; King, A; Phillips, I1
King, A; Phillips, I; Shannon, K; Slegg, J1
Finch, R; Martin, J; Pilkington, R1
King, A; Phillips, I1
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C1
Floyd-Reising, SA; Hindler, JA; Kelley, SG; Young, LS1
Milatovic, D1

Other Studies

20 other study(ies) available for ci 934 and ciprofloxacin

ArticleYear
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.
    Journal of medicinal chemistry, 1992, Dec-11, Volume: 35, Issue:25

    Topics: Animals; Anti-Infective Agents; Cricetinae; Cricetulus; Fluoroquinolones; Microbial Sensitivity Tests; Structure-Activity Relationship

1992
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:3

    Topics: Alkylation; Aminoquinolines; Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxyquinolines; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1991
Quinolone antibacterial agents substituted at the 7-position with spiroamines. Synthesis and structure-activity relationships.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:8

    Topics: Bacteria; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Piperazines; Pyrrolidines; Quinolines; Spiro Compounds; Structure-Activity Relationship

1990
1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Carboxylic Acids; Chemical Phenomena; Chemistry; Mice; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1988
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1986
Artificial neural network applied to prediction of fluorquinolone antibacterial activity by topological methods.
    Journal of medicinal chemistry, 2000, Mar-23, Volume: 43, Issue:6

    Topics: Algorithms; Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Neural Networks, Computer; Structure-Activity Relationship

2000
In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:9

    Topics: Aeromonas; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Osmolar Concentration; Oxolinic Acid; Quinolones; Sodium Chloride

1990
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines

1986
Comparative in vitro activity of the new quinolone CI-934.
    European journal of clinical microbiology, 1986, Volume: 5, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Haemophilus influenzae; Ofloxacin; Oxazines; Quinolines; Streptococcus

1986
In vitro activity of CI-934, a new quinolone antimicrobial, against gram-positive bacteria.
    Diagnostic microbiology and infectious disease, 1986, Volume: 5, Issue:4

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolines; Streptococcus

1986
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
    Journal of clinical microbiology, 1987, Volume: 25, Issue:5

    Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Erythromycin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Quinolines; Streptococcus; Thienamycins; Vancomycin

1987
In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines

1987
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2

    Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica

1987
The in-vitro activity of PD127,391, a new quinolone.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:2

    Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests

1988
The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Fluoroquinolones; Nalidixic Acid; Naphthyridines; Quinolines; Staphylococcus; Streptococcus

1986
In vitro assessment of CI-934--a new quinolone derivative.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:6

    Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin

1986
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl D

    Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines

1986
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Regression Analysis

1987
In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
    Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Quinolines; Vancomycin

1987
Intraphagocytic activity of ciprofloxacin and CI 934.
    European journal of clinical microbiology, 1986, Volume: 5, Issue:6

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Humans; Kinetics; Neutrophils; Phagocytosis; Quinolines; Staphylococcus aureus

1986